Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress
Stock Information for Humanigen Inc.
Loading
Please wait while we load your information from QuoteMedia.